Insights

2 ASX shares liked by this top fund manager

Australian Clinical Labs is one of the ASX shares that is liked by WAM.
The post 2 ASX shares liked by this top fund manager appeared first on The Motley Fool Australia. –

The fund manager Wilson Asset Management (WAM) has told investors about two ASX shares that it has in its portfolio.

WAM operates several listed investment companies (LICs). Some focus on larger companies like WAM Leaders Ltd (ASX: WLE).

There’s also one called WAM Capital Limited (ASX: WAM) which targets “the most compelling undervalued growth opportunities in the Australian market.”

The WAM Capital portfolio has delivered an investment return of 16.5% per annum since inception in August 1999, before fees, expenses and taxes. This gross return outperformed the S&P/ASX All Ordinaries Accumulation Index return of 8.7% per annum over the same timeframe.

These are the two ASX shares that WAM Capital outlined in its most recent monthly update:

Australian Clinical Labs Ltd (ASX: ACL)

WAM explained that Australian Clinical Labs is a healthcare business that provides pathology services in Australia. It has 86 accredited laboratories which provide services for more than 8 million people and 90 public and private hospitals.

The fund manager noted that the ASX share traded below its initial listing price after listing a few months ago. However, WAM reckons the market didn’t understand its earnings power because the focus had been on automating systems and processes, coupled with increased levels of COVID-19 testing – the Australian Clinical Labs share price grew 14.1% during the month.

Why does WAM like the business now? It thinks the company will be able to increase its market share, which can be aided by earnings accretive acquisitions with its balance sheet.

The fund manager points out that Australian Clinical Labs was valued at an approximate 30% discount compared to its peers. This could change if the business can deliver the potential superior organic growth rates and successful acquisitions that WAM is expecting. This could lead to a re-rating of the business.

Select Harvests Limited (ASX: SHV)

The other ASX share that WAM currently likes is the leading almond producer Select Harvests. It is one of the largest growers in Australia.

WAM points out that Select Harvests has already benefited from “considerable growth” in Australian almond production and consumption in the last decade.

Australia is now the second biggest producer of almonds in the world, after the US.

One of the things that WAM noticed from a recent Select Harvests update was that there is growing demand for almonds with Australian almond exports up 67% on the prior period.

The almond business is also seeing higher market prices for its commodity. A downgrade of the US 2021 crop harvest is helping drive an increase in the overall market price for almonds by $0.50 per kilo to a range of $6.75 per kilo to $7.25 per kilo.

Wilson Asset Management believes that almond prices are set to stage a “multi-year recovery” which will help Select Harvests with its increased ownership of almond farms after the Piangil Orchard acquisition in October 2020.

The post 2 ASX shares liked by this top fund manager appeared first on The Motley Fool Australia.

Should you invest $1,000 in Select Harvests right now?

Before you consider Select Harvests, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Select Harvests wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Why is WAM Capital (ASX:WAM) underperforming the ASX 200 in 2021?
These 2 ASX shares have been named as opportunities

Select Harvests (ASX:SHV) share price edges higher after business update
New ASX share everyone’s ignoring is ready to skyrocket: analysts

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!